Robert E. Mosser

Array ( [id] => 6196736 [patent_doc_number] => 20110028494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'HCV NS3 Protease Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/989886 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47089 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028494.pdf [firstpage_image] =>[orig_patent_app_number] => 11989886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530505 [patent_doc_number] => 07842727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Histone deacetylase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/489519 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25135 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842727.pdf [firstpage_image] =>[orig_patent_app_number] => 11489519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5243014 [patent_doc_number] => 20070021509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Phosphate transport inhibitors' [patent_app_type] => utility [patent_app_number] => 11/489286 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21065 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021509.pdf [firstpage_image] =>[orig_patent_app_number] => 11489286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795423 [patent_doc_number] => 08124129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Crystalline form of the compound A-348441' [patent_app_type] => utility [patent_app_number] => 11/988330 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3442 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124129.pdf [firstpage_image] =>[orig_patent_app_number] => 11988330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11277320 [patent_doc_number] => 09493798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Process for producing unsaturated fatty acid-containing oils' [patent_app_type] => utility [patent_app_number] => 11/482901 [patent_app_country] => US [patent_app_date] => 2006-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4544 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11482901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480765 [patent_doc_number] => 20090203722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Novel compositions and methods for enhancing potency or reducing adverse side effects of opiold agonists' [patent_app_type] => utility [patent_app_number] => 11/456079 [patent_app_country] => US [patent_app_date] => 2006-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 147050 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203722.pdf [firstpage_image] =>[orig_patent_app_number] => 11456079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480719 [patent_doc_number] => 20090203676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'G-protein Coupled Receptor Agonists' [patent_app_type] => utility [patent_app_number] => 11/922826 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23136 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203676.pdf [firstpage_image] =>[orig_patent_app_number] => 11922826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247959 [patent_doc_number] => 20070244193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Intramuscular antiviral treatments' [patent_app_type] => utility [patent_app_number] => 11/476401 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4520 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244193.pdf [firstpage_image] =>[orig_patent_app_number] => 11476401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4433388 [patent_doc_number] => 07897645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Herpesvirus-derived therapeutic agent for pain' [patent_app_type] => utility [patent_app_number] => 11/922593 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4374 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897645.pdf [firstpage_image] =>[orig_patent_app_number] => 11922593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923900 [patent_doc_number] => 20060241021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Methods of treating cognitive dysfunction by modulating brain energy metabolism' [patent_app_type] => utility [patent_app_number] => 11/473935 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8728 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241021.pdf [firstpage_image] =>[orig_patent_app_number] => 11473935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424875 [patent_doc_number] => 20100168097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Non-Nucleoside Reverse Transcriptase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/922672 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25288 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168097.pdf [firstpage_image] =>[orig_patent_app_number] => 11922672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285564 [patent_doc_number] => 20090099239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Antiviral Compounds and Methods' [patent_app_type] => utility [patent_app_number] => 11/922281 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8950 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099239.pdf [firstpage_image] =>[orig_patent_app_number] => 11922281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539793 [patent_doc_number] => 20090221598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Use of Sanglifehrin in HCV' [patent_app_type] => utility [patent_app_number] => 11/917781 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8885 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221598.pdf [firstpage_image] =>[orig_patent_app_number] => 11917781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859803 [patent_doc_number] => 20060229262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant' [patent_app_type] => utility [patent_app_number] => 11/449646 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3563 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229262.pdf [firstpage_image] =>[orig_patent_app_number] => 11449646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5689004 [patent_doc_number] => 20060287319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Anti-viral compositions comprising heterocyclic substituted phenyl furans and related compounds' [patent_app_type] => utility [patent_app_number] => 11/448439 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10634 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287319.pdf [firstpage_image] =>[orig_patent_app_number] => 11448439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270945 [patent_doc_number] => 20090074721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'METHODS FOR TREATING VIRAL INFECTION WITH ORAL OR INJECTIBEL DRUG SOLUTION' [patent_app_type] => utility [patent_app_number] => 11/916628 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10363 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074721.pdf [firstpage_image] =>[orig_patent_app_number] => 11916628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624931 [patent_doc_number] => 20060263436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Antifungal compositions with improved bioavailability' [patent_app_type] => utility [patent_app_number] => 11/445849 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7046 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263436.pdf [firstpage_image] =>[orig_patent_app_number] => 11445849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643364 [patent_doc_number] => 20060281819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Suppression of HIV-1 replication via inhibition of human flap endonuclease-1-mediated HIV-1 central DNA flap processing' [patent_app_type] => utility [patent_app_number] => 11/440581 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12374 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281819.pdf [firstpage_image] =>[orig_patent_app_number] => 11440581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625918 [patent_doc_number] => 20060264423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Methylene Blue Therapy of Viral Disease' [patent_app_type] => utility [patent_app_number] => 11/419426 [patent_app_country] => US [patent_app_date] => 2006-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11558 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264423.pdf [firstpage_image] =>[orig_patent_app_number] => 11419426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515515 [patent_doc_number] => 20090215822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Substituted Oxadiazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate Receptors' [patent_app_type] => utility [patent_app_number] => 11/920603 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26072 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215822.pdf [firstpage_image] =>[orig_patent_app_number] => 11920603 [rel_patent_id] =>[rel_patent_doc_number] =>)